ATE76750T1 - Anwendung eines prostaglandins in mischung mit einem adrenergischen blocker zur verminderung des augen-innendruckes. - Google Patents

Anwendung eines prostaglandins in mischung mit einem adrenergischen blocker zur verminderung des augen-innendruckes.

Info

Publication number
ATE76750T1
ATE76750T1 AT88104999T AT88104999T ATE76750T1 AT E76750 T1 ATE76750 T1 AT E76750T1 AT 88104999 T AT88104999 T AT 88104999T AT 88104999 T AT88104999 T AT 88104999T AT E76750 T1 ATE76750 T1 AT E76750T1
Authority
AT
Austria
Prior art keywords
prostaglandin
eye
intraocular pressure
adrenegic
blocker
Prior art date
Application number
AT88104999T
Other languages
German (de)
English (en)
Inventor
Laszlo Z Bito
Johan Wilhelm Stjernschantz
Original Assignee
Univ Columbia
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21876714&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE76750(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Columbia, Pharmacia Ab filed Critical Univ Columbia
Application granted granted Critical
Publication of ATE76750T1 publication Critical patent/ATE76750T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT88104999T 1987-04-03 1988-03-28 Anwendung eines prostaglandins in mischung mit einem adrenergischen blocker zur verminderung des augen-innendruckes. ATE76750T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3448487A 1987-04-03 1987-04-03
EP88104999A EP0286903B2 (en) 1987-04-03 1988-03-28 Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure

Publications (1)

Publication Number Publication Date
ATE76750T1 true ATE76750T1 (de) 1992-06-15

Family

ID=21876714

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88104999T ATE76750T1 (de) 1987-04-03 1988-03-28 Anwendung eines prostaglandins in mischung mit einem adrenergischen blocker zur verminderung des augen-innendruckes.

Country Status (9)

Country Link
EP (1) EP0286903B2 (https=)
JP (1) JP2726672B2 (https=)
AT (1) ATE76750T1 (https=)
AU (1) AU607981B2 (https=)
CA (1) CA1314220C (https=)
DE (1) DE3871596T3 (https=)
ES (1) ES2042625T5 (https=)
GR (2) GR3004794T3 (https=)
HU (1) HU211835A9 (https=)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334168C (en) * 1988-04-26 1995-01-31 Louis M. De Santis Antiglaucoma compositions containing combinations of .alpha.-2 agonists and .beta. blockers
US5173507A (en) * 1988-07-18 1992-12-22 Alcon Laboratories, Inc. Prostaglandin combinations in glaucoma therapy
US4994274A (en) * 1989-07-27 1991-02-19 Allergan, Inc. Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
US5028624A (en) * 1989-07-27 1991-07-02 Allergan, Inc. Intraocular pressure reducing 9,15-diacyl prostaglandins
CA2021316C (en) * 1989-07-27 2000-10-24 Ming Fai Chan Intraocular pressure reducing 11-acyl prostaglandins
US5055467A (en) * 1989-11-13 1991-10-08 Allergan, Inc. Pharmaceutical epinephrine-pilocarpine compounds
US5198545A (en) * 1989-11-13 1993-03-30 Allergan, Inc. Pharmaceutical epinephrine-pilocarpine compounds and process of preparation thereof
US5011856A (en) * 1990-03-12 1991-04-30 Allergan, Inc. Use of prostaglandin F3 α as an ocular hypotensive agent
CA2042934C (en) * 1990-05-22 2002-04-23 Ryuji Ueno Treatment of ocular hypertension with an ocular synergistic combination
ES2084771T3 (es) * 1990-05-22 1996-05-16 R Tech Ueno Ltd Tratamiento de la hipertension ocular con la ayuda de una combinacion sinergica.
DE69100171T2 (de) * 1990-05-22 1993-10-28 Ueno Seiyaku Oyo Kenkyujo Kk Synergistische Kombination zur ophthalmischen Verwendung.
US5238961A (en) * 1990-06-14 1993-08-24 Allergan, Inc. Pgf 1-alcohols and their use as ocular hypotensives
TW210287B (https=) * 1991-03-01 1993-08-01 Kabushikaisha Ueno Seiyaku Oyo Kenkyujo
DE69232150T2 (de) * 1992-03-19 2002-03-07 R-Tech Ueno, Ltd. Behandlung von Augenhochdruck mit Betablockern und Prostansäurederivaten
JPH06107547A (ja) * 1992-10-01 1994-04-19 Aarutetsuku Ueno:Kk 眼科用組成物
WO1994008585A1 (en) * 1992-10-13 1994-04-28 Alcon Laboratories, Inc. Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma
US5574066A (en) * 1992-10-28 1996-11-12 Allergan Intraocular pressure reducing 15-acyl prostaglandins
SE9402816D0 (sv) * 1994-08-24 1994-08-24 Pharmacia Ab Method and meams for drug administration
US5698733A (en) * 1994-09-30 1997-12-16 Alcon Laboratories, Inc. Use of 9-deoxy prostaglandin derivatives to treat glaucoma
ATE311880T1 (de) * 1998-01-23 2005-12-15 Einar Stefansson Carbonische anhydrase inhibitor zur steigerung des sauerstoffdrucks im sehnerv und retina
WO2002085372A1 (en) * 2001-04-19 2002-10-31 Teika Pharmaceutical Co., Ltd. Medicines and medicinal kits
TWI298257B (en) * 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
AU2007200821A1 (en) * 2001-05-31 2007-03-15 Allergan, Inc. Hypotensive lipid and timolol compositions and methods of using same
TW200305424A (en) 2002-01-29 2003-11-01 Santen Pharmaceutical Co Ltd Glaucoma-treating agent comprising bunazosin and prostaglandin
ATE546143T1 (de) * 2002-08-29 2012-03-15 Santen Pharmaceutical Co Ltd Mittel zur behandlung von glaukom mit einem rho- kinase-hemmer und prostaglandinen
US7972612B2 (en) 2002-11-18 2011-07-05 Santen Pharmaceutical Co., Ltd. Remedy for glaucoma comprising Rho kinase inhibitor and β-blocker
US7186744B2 (en) * 2003-11-13 2007-03-06 Allergan, Inc. Prostamides for the treatment of glaucoma and related diseases
PT1905452E (pt) 2005-07-12 2013-07-16 Kowa Co Agente para a prevenção ou tratamento do glaucoma
EP2127638A1 (en) 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
EP2478906A4 (en) * 2009-09-17 2013-02-20 Senju Pharma Co AQUEOUS OPHTHALMIC DROPS THAT CONTAIN LATANOPROST, AND A METHOD OF INHIBITING ADSORPTION OF LATANOPROST ON A RESIN
US9078854B2 (en) 2010-07-29 2015-07-14 Allergan, Inc. Preservative free bimatoprost and timolol solutions
US9061034B2 (en) 2010-07-29 2015-06-23 Allergan, Inc. Preservative free bimatoprost and timolol solutions
CN103338772A (zh) 2011-02-04 2013-10-02 兴和株式会社 用于预防或治疗青光眼的药物疗法
JP6193655B2 (ja) * 2012-07-13 2017-09-06 参天製薬株式会社 スルホンアミド化合物の組み合わせ
WO2018033854A1 (en) 2016-08-15 2018-02-22 Santen Pharmaceutical Co., Ltd. Ophthalmic composition and a method for treating ocular hypertension and glaucoma
WO2019124487A1 (ja) 2017-12-21 2019-06-27 参天製薬株式会社 オミデネパグの組合せ
CA3086457A1 (en) 2017-12-21 2019-06-27 Santen Pharmaceutical Co., Ltd. Medicament comprising combination of sepetaprost and rho-associated coiled-coil containing protein kinase inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454154A (en) * 1981-06-23 1984-06-12 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
DE3300933A1 (de) * 1983-01-13 1984-07-19 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von d,l- und d-carazolol als antiglaukommittel sowie arzneimittel, die diese stoffe enthalten
DE3785602T2 (de) * 1986-03-13 1993-09-02 Univ Columbia Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom.

Also Published As

Publication number Publication date
EP0286903A1 (en) 1988-10-19
JPS63313728A (ja) 1988-12-21
EP0286903B1 (en) 1992-06-03
DE3871596T2 (de) 1993-01-21
HU211835A9 (en) 1995-12-28
ES2042625T3 (es) 1993-12-16
GR3004794T3 (https=) 1993-04-28
DE3871596D1 (de) 1992-07-09
AU607981B2 (en) 1991-03-21
DE3871596T3 (de) 2000-09-07
CA1314220C (en) 1993-03-09
JP2726672B2 (ja) 1998-03-11
ES2042625T5 (es) 2000-07-16
EP0286903B2 (en) 2000-03-29
AU1387088A (en) 1988-10-06
GR3033721T3 (en) 2000-10-31

Similar Documents

Publication Publication Date Title
ATE76750T1 (de) Anwendung eines prostaglandins in mischung mit einem adrenergischen blocker zur verminderung des augen-innendruckes.
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
AU6877994A (en) Use of cloprostenol, fluprostenol and their analogues to treat glaucoma and ocular hypertension
DE69634414D1 (de) Verwendung von substituierten isochinolinsulfonyl-verbindungen zur herstellung eines medikaments für die behandlung von glaukom und okularer ischämie
PL316584A1 (en) Ophtalmic composition of reduced viscosity
ECSP034815A (es) "composiciones de timolol y de lipido hipotensivas y los metodos para utilizarlas"
MX9805020A (es) Analogos de prostaglandinas de tetrahidrofurano substituido como hipotensores oculares.
IE811654L (en) Ophthalmic composition
DK0561073T3 (da) Behandling af øjenhypertension
FI911131A0 (fi) Menetelmä viherkaihia estävien 3-aryylikarbonyyli-1-aminoalkyyli-1H-indoliyhdisteiden valmistamiseksi
EP0366279A3 (en) Ocular hypotensive agents
ATE78031T1 (de) Prostaglandin-derivate zur behandlung von glaucoma oder augenueberdruck.
TW427913B (en) Eye drop composition comprising pilocarpine and a β-blocking agent and process making the same
HU9302590D0 (en) Process and composition for treating eyes
AU1545788A (en) A composition for the topical treatment of glaucoma or ocular hypertension
KR920019348A (ko) 탄산탈수효소 억제제 및 β-아드레날린 길항제의 배합물을 포함하는 안과용 조성물
ATE117208T1 (de) Behandlung von intraokularem druck mit einer ophthalmischen synergistischen kombination.
DE69116224D1 (de) Behandlung von intraokularem Druck mit einer synergischen Kombination
PT73152A (en) Process for preparing a composition to reduce intra-ocular pressure
ATE169499T1 (de) Topische antiglaukoma zusammensetzungen, enthaltend karbonhydrasehemmer und beta-blocker
ATE23112T1 (de) Verwendung von 1-(p-isopropoxyethoxymethylphenoxy)-3-isopropylamino-propan-2-ol zur herstellung eines arzneimittels zur senkung des augeninnendrucks.
IE872994L (en) The use of alpha-21 selective adrenergic receptor agonists¹¹in memory enhancement
ATE289198T1 (de) Verwendung von flunarizin zur topischen behandlung ocularem hochdruck
DE69301387D1 (de) Behandlung des Glaukoms mit synergistischer Kombination
EP0373592A3 (en) Oculoselective beta-blockers as antiglaucoma agents

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time